Detalhe da pesquisa
1.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385243
2.
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Leukemia
; 36(7): 1870-1878, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562406
3.
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing.
Eur J Cancer
; 42(2): 171-8, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16406576